60 Degrees Pharmaceuticals, Inc.
SXTP
$2.93
-$0.08-2.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 681.30K | 462.60K | 441.30K | 378.20K | 253.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 681.30K | 462.60K | 441.30K | 378.20K | 253.60K |
| Cost of Revenue | 3.61M | 4.39M | 3.67M | 872.40K | 666.90K |
| Gross Profit | -2.93M | -3.92M | -3.23M | -494.20K | -413.40K |
| SG&A Expenses | 5.03M | 5.11M | 5.21M | 4.54M | 4.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.40M | 10.00M | 9.38M | 5.91M | 5.41M |
| Operating Income | -9.72M | -9.53M | -8.94M | -5.54M | -5.15M |
| Income Before Tax | -7.96M | -7.95M | -1.62M | -788.10K | -3.81M |
| Income Tax Expenses | 300.00 | 900.00 | 700.00 | 400.00 | 400.00 |
| Earnings from Continuing Operations | -7.96 | -7.95 | -1.62 | -0.79 | -3.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.60K | 38.60K | 47.60K | 53.10K | 48.10K |
| Net Income | -7.95M | -7.91M | -1.57M | -735.20K | -3.77M |
| EBIT | -9.72M | -9.53M | -8.94M | -5.54M | -5.15M |
| EBITDA | -9.66M | -9.49M | -8.89M | -5.49M | -5.10M |
| EPS Basic | -26.22 | -45.92 | 4.28 | -58.76 | -128.32 |
| Normalized Basic EPS | -15.34 | -26.53 | -34.40 | -57.31 | -93.09 |
| EPS Diluted | -26.22 | -45.92 | 4.28 | -58.76 | -128.32 |
| Normalized Diluted EPS | -15.34 | -26.53 | -34.40 | -57.31 | -93.09 |
| Average Basic Shares Outstanding | 1.82M | 957.30K | 558.30K | 394.90K | 264.60K |
| Average Diluted Shares Outstanding | 1.82M | 957.30K | 558.30K | 394.90K | 264.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |